Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Captor Capital: Building a Vertically-Integrated Cannabis Empire -- CFN Media


Posted on: 20 Aug 18

SEATTLE, WA, Aug. 20, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Captor Capital Corp. (CSE: CPTR) (FFT: NMV) (OTC: NWURF). Captor is a vertically-integrated cannabis company that owns and operates advanced growing facilities that produce high-quality marijuana. Captor then distributes the product throughout its wholly-owned dispensary network, including leading dispensaries in California. The company also plans to rapidly expand this footprint with one new acquisition and another planned acquisition in the state.

The U.S. cannabis industry is projected to exceed $50 billion in size by 2026, according to Cowen & Co., driven by the legalization of recreational cannabis across a growing number of states. While Colorado and Washington were early pioneers, California is poised to become the single largest market in the U.S. and one of the largest in the world. As a result, investors may want to take a closer look at companies focused on the state.

Growing Network of Dispensaries in California

Captor Capital owns two MedMen-branded dispensaries in West Hollywood and Santa Ana, California through its I-5 Holdings subsidiary. The high-end dispensaries are operated and managed by MedMen Enterprises Inc. (CSE: MMEN) under separate management contracts, possess licenses to sell recreational cannabis into the state’s market, and already generated gross revenue of US$7.57 million during the first quarter of this year.

“We are now seeing our first investment target in the California cannabis industry produce some very impressive numbers,” said Captor Capital CEO John Zorbas. “Our intention is to continue with our strategic focus of making investments in high-end cannabis retail stores and cultivation facilities in California as demonstrated by Captor’s recently announced proposed investment in Growth Network Solutions.”

In April, the company announced a non-binding term sheet with Growth Network Holdings Inc. to acquire a 30 percent equity stake and an option to acquire the remaining shares. Growth Network operates two retail dispensaries in the Los Angeles area and plans to open three more locations this year. Captor also acquired Chai Cannabis Inc. in August, which owns a recreational cannabis dispensary in Santa Cruz, as well as a delivery license.

Captor plans to continue its acquisition spree over the coming months. According to a press release in early August, the company is already in the process of acquiring two more dispensaries in Monterey Bay and Silicon Beach, which would bring its total to five retail cannabis dispensaries in California.

Cannabis Cultivation Facilities

Captor Capital leased two cannabis cultivation facilities in Washington State that are equipped to produce high-grade cannabis through its I-5 Holdings subsidiary. Currently, the company is in the process of sub-leasing these facilities to licensed growers, as well as negotiating license agreements with the sub-lessee cultivators for the use of certain intellectual property, such as operational procedures and cultivation processes.

In addition to these leases, the company’s proposed acquisition of Growth Network would include a 45,000 sq. ft. cultivation facility in California that sits on 29.5 acres of land. Growth Network plans to build a new 500,000 sq. ft. cultivation facility on the land, which would make it one of the largest indoor cultivation facilities in the state, as well as extraction, manufacturing, packaging, distribution, and testing facilities.

“We are very pleased to have reached this agreement in principle with Captor and we are excited to be working with investors that understand not only us and our business, but our market,” said Growth Network CEO John Jezzini. “By having all of these facilities under one roof, our business park will provide every service required, from seed to retail sale.”

The company also plans to build out its manufacturing footprint beyond just cultivation. In early-August, the company announced that it’s in the final stages of negotiation with Mellow Extracts LLC to acquire its state of the art extraction lab in Costa Mesa. The lab will be used to produce ultra-premium oil and provide service-for-hire extraction, as well as co-packing capabilities for white label and private label cannabis brands.

Looking Ahead

Captor Capital Corp. (CSE: CPTR) (FFT: NMV) (OTC: NWURF) represents a compelling investment opportunity in the U.S. cannabis industry. With existing recreational cannabis dispensaries operating in California, the proposed acquisition of cultivation facilities there, and cultivation facilities coming online in Washington, the company offers both an efficient vertically-integrated supply chain from an operations standpoint and a diversified opportunity from an investment standpoint.

For more information, visit the company’s website at www.capitalcapital.com.

Please follow the link to read the full article: http://www.cannabisfn.com/captor-capital-building-vertically-integrated-cannabis-empire/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided onhttp://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

CONTACT: Contact CFN Media Frank Lane 206-369-7050 flane@cannabisfn.comGlobeNewswire
globenewswire.com

Last updated on: 21/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.